Multi-omics integrated analysis reveals the therapeutic mechanism of 919 formula in metabolic dysfunction-associated steatotic liver disease.
BACKGROUND Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent chronic liver disease worldwide and is driven by metabolic stress-induced inflammation. Emerging evidence implicates cytotoxic CD8⁺ T cells as key contributors to the progression of MASLD. However, therapeutic strategies s...